Breyanzi

View All

Deerfield Dana Farber Deal FDA Nod to BMS Breyanzi & TG Ukoniq
Deerfield/ Dana-Farber’s USD 130 Million Cancer Research Deal; FDA-Approval to BMS’ Breyanzi & TG Therapeutics’ Ukoniq; EU Marketing Rights for ViiV Healthcare’s Rukobia

Deerfield and Dana-Farber Establish Links in USD 130 Million Cancer Research Deal  Deerfield Management has entered into a research agreement with Dana-Farber Cancer Institute to fuel the development of therapeutics and diagnostics for cancer. The move came not long after healthcare investor giant Deerfield...

Find More